Report cover image

Single-use Bioreactors Market Size, Share & Trends Analysis Report By Product, By Type, By Type Of Cell, By Molecule Type, By Application, By End Use, By Usage Type, By Region, And Segment Forecasts, 2025 - 2033

Publisher Grand View Research
Published Sep 12, 2025
Length 120 Pages
SKU # GV20471031

Description

Single-use Bioreactors Market Summary

The global single-use bioreactors market size was estimated at USD 4.58 billion in 2024 and is projected to reach USD 18.65 billion by 2033, growing at a CAGR of 17.12% from 2025 to 2033. Single-use systems are emerging as an important technology for pharmaceutical and mammalian cell culture applications.

They are particularly well-suited for biopharmaceutical production, where prevailing market trends call for quick, easy, and flexible deployment. In addition, with comprehensive qualification and validation procedures, the use of single-use bioreactors lowers the possibility of cross-contamination and improves process safety in highly potent biopharmaceutical compounds. These factors are anticipated to drive the market growth.

In addition, some of the manufacturers are using bioreactors to culture suitable host cells for the coronavirus, in order to study the viral pathogenesis in humans. Moreover, in the past few months, the single-use bioreactor manufacturers have undertaken numerous collaborative initiatives to develop biologics/vaccines as potential therapeutics against the COVID-19. For instance, ABEC has focused on customizing the process services and solutions throughout the manufacturing and development of the entire range of biopharmaceutical products, with the aid of its single-use solutions.

The range of stainless-steel bioreactors and associated high capital costs have become a challenge due to the changing demand for biopharmaceuticals. SUBs' versatility to meet the rising demand for biopharmaceuticals has enabled them to successfully address the issues related to traditional bioreactors. Flexibility offered by single-use bioreactors is one of the main encouraging factors for investing in technology that further drives the growth of the single-use bioreactors industry.

Additionally, it is projected that in the upcoming years, the use of disposable bioreactors will pick up steam due to the increased demand for biopharmaceuticals across the globe. Small-scale, bench-top SUBs reduce the requirement for assembling, cleaning, and autoclaving, which leads to quicker turnaround times. The advantages offered by SUBs motivate their use for the manufacturing of biopharmaceuticals.

Global Single-use Bioreactors Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the single-use bioreactors market on the basis of product, type, type of cell, molecule type, application, end use, usage type, and region:
  • Product Scope Outlook (Revenue, USD Million, 2021 - 2033)
  • Single-use bioreactor systems
  • Up to 10L
  • 11-100L
  • 101-500L
  • 501-1500L
  • Above 1500L
  • Single-use media bags
  • 2D Bags
  • 3D Bags
  • Others
  • Single-use Filtration Assemblies
  • Other Products
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Stirred-tank SUBs
  • Wave-induced SUBs
  • Bubble-column SUBs
  • Other SUBs
  • Type of Cell Outlook (Revenue, USD Million, 2021 - 2033)
  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells
  • Other Cells
  • Molecule Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Monoclonal Antibodies
  • Vaccines
  • Gene Modified Cells
  • Stem Cells
  • Other Molecules
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Research and Development (R&D) or Process Development
  • Bioproduction
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biopharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes
  • Usage Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Lab-scale Production
  • Pilot-scale Production
  • Large-scale Production
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

120 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Type
1.2.3. Type of Cell
1.2.4. Molecule Type
1.2.5. Application
1.2.6. End Use
1.2.7. Usage Type
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Landscape Snapshot
Chapter 3. Single-use Bioreactors Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing adoption of SUBs among small companies and startups
3.2.1.2. Technological advancements in SUBs
3.2.2. Market restraint analysis
3.2.2.1. Regulatory Concerns related to single-use bioreactors
3.3. Industry Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Product Business Analysis
4.1. Segment Dashboard
4.2. Single-use Bioreactors Market: Product Movement Analysis
4.3. Single-use Bioreactor Systems
4.3.1. Single-use bioreactor systems market estimates and forecasts 2021 - 2033 (USD Million)
4.3.2. Up to 10L
4.3.2.1. Up to 10L market estimates and forecasts 2021 - 2033 (USD Million)
4.3.3. 11-100L
4.3.3.1. 11-100L market estimates and forecasts 2021 - 2033 (USD Million)
4.3.4. 101-500L
4.3.4.1. 101-500L market estimates and forecasts 2021 - 2033 (USD Million)
4.3.5. 501-1500L
4.3.5.1. 501-1500L market estimates and forecasts 2021 - 2033 (USD Million)
4.3.6. Above 1500L
4.3.6.1. Above 1500L market estimates and forecasts 2021 - 2033 (USD Million)
4.4. Single-use Media Bags
4.4.1. Single-use media bags market estimates and forecasts 2021 - 2033 (USD Million)
4.4.2. 2D Bags
4.4.2.1. 2D bags market estimates and forecasts 2021 - 2033 (USD Million)
4.4.3. 3D Bags
4.4.3.1. 3D bags market estimates and forecasts 2021 - 2033 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts 2021 - 2033 (USD Million)
4.5. Single-use Filtration Assemblies
4.5.1. Single-use filtration assemblies market estimates and forecasts 2021 - 2033 (USD Million)
4.6. Other Products
4.6.1. Other products market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 5. Type Business Analysis
5.1. Segment Dashboard
5.2. Single-use Bioreactors Market: Type Movement Analysis
5.3. Stirred-tank SUBs
5.3.1. Stirred-tank SUBs market estimates and forecasts 2021 - 2033 (USD Million)
5.4. Wave-induced SUBs
5.4.1. Wave-induced SUBs market estimates and forecasts 2021 - 2033 (USD Million)
5.5. Bubble-column SUBs
5.5.1. Bubble-column SUBs market estimates and forecasts 2021 - 2033 (USD Million)
5.6. Other SUBs
5.6.1. Other SUBs market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 6. Type of Cell Business Analysis
6.1. Segment Dashboard
6.2. Single-use Bioreactors Market: Type of Cell Movement Analysis
6.3. Mammalian Cells
6.3.1. Mammalian cells market estimates and forecasts 2021 - 2033 (USD Million)
6.4. Bacterial Cells
6.4.1. Bacterial cells market estimates and forecasts 2021 - 2033 (USD Million)
6.5. Yeast Cells
6.5.1. Yeast cells market estimates and forecasts 2021 - 2033 (USD Million)
6.6. Other Cells
6.6.1. Other cells market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 7. Molecule Type Business Analysis
7.1. Segment Dashboard
7.2. Single-use Bioreactors Market: Molecule Type Movement Analysis
7.3. Monoclonal Antibodies
7.3.1. Monoclonal antibodies market estimates and forecasts 2021 - 2033 (USD Million)
7.4. Vaccines
7.4.1. Vaccines market estimates and forecasts 2021 - 2033 (USD Million)
7.5. Gene Modified Cells
7.5.1. Gene modified cells market estimates and forecasts 2021 - 2033 (USD Million)
7.6. Stem Cells
7.6.1. Stem cells market estimates and forecasts 2021 - 2033 (USD Million)
7.7. Other Molecules
7.7.1. Other molecules market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 8. Application Business Analysis
8.1. Segment Dashboard
8.2. Single-use Bioreactors Market: Application Movement Analysis
8.3. Research and Development (R&D) or Process Development
8.3.1. Research and development (R&D) or process development market estimates and forecasts 2021 - 2033 (USD Million)
8.4. Bioproduction
8.4.1. Bioproduction market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 9. End Use Business Analysis
9.1. Segment Dashboard
9.2. Single-use Bioreactors Market: End Use Movement Analysis
9.3. Pharmaceutical & Biopharmaceutical Companies
9.3.1. Pharmaceutical & biopharmaceutical companies market estimates and forecasts 2021 - 2033 (USD Million)
9.4. CROs & CMOs
9.4.1. CROs & CMOs market estimates and forecasts 2021 - 2033 (USD Million)
9.5. Academic & Research Institutes
9.5.1. Academic & research institutes market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 10. Usage Type Business Analysis
10.1. Segment Dashboard
10.2. Single-use Bioreactors Market: Usage Type Movement Analysis
10.3. Lab-Scale Production
10.3.1. Lab-scale production market estimates and forecasts 2021 - 2033 (USD Million)
10.4. Pilot-Scale Production
10.4.1. Pilot-scale production market estimates and forecasts 2021 - 2033 (USD Million)
10.5. Large-Scale Production
10.5.1. Large-scale production market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 11. Regional Business Analysis
11.1. Regional Dashboard
11.2. Single-use Bioreactors Market: Regional Outlook
11.3. North America
11.3.1. North America market estimates and forecasts 2021 - 2033 (USD Million)
11.3.2. U.S.
11.3.2.1. Key country dynamics
11.3.2.2. Competitive scenario
11.3.2.3. Regulatory framework
11.3.2.4. U.S. market estimates and forecasts 2021 - 2033 (USD Million)
11.3.3. Canada
11.3.3.1. Key country dynamics
11.3.3.2. Competitive scenario
11.3.3.3. Regulatory framework
11.3.3.4. Canada market estimates and forecasts 2021 - 2033 (USD Million)
11.3.4. Mexico
11.3.4.1. Key country dynamics
11.3.4.2. Competitive scenario
11.3.4.3. Regulatory framework
11.3.4.4. Mexico market estimates and forecasts 2021 - 2033 (USD Million)
11.4. Europe
11.4.1. Europe market estimates and forecasts 2021 - 2033 (USD Million)
11.4.2. UK
11.4.2.1. Key country dynamics
11.4.2.2. Competitive scenario
11.4.2.3. Regulatory framework
11.4.2.4. UK market estimates and forecasts 2021 - 2033 (USD Million)
11.4.3. Germany
11.4.3.1. Key country dynamics
11.4.3.2. Competitive scenario
11.4.3.3. Regulatory framework
11.4.3.4. Germany market estimates and forecasts 2021 - 2033 (USD Million)
11.4.4. France
11.4.4.1. Key country dynamics
11.4.4.2. Competitive scenario
11.4.4.3. Regulatory framework
11.4.4.4. France market estimates and forecasts 2021 - 2033 (USD Million)
11.4.5. Italy
11.4.5.1. Key country dynamics
11.4.5.2. Competitive scenario
11.4.5.3. Regulatory framework
11.4.5.4. Italy market estimates and forecasts 2021 - 2033 (USD Million)
11.4.6. Spain
11.4.6.1. Key country dynamics
11.4.6.2. Competitive scenario
11.4.6.3. Regulatory framework
11.4.6.4. Spain market estimates and forecasts 2021 - 2033 (USD Million)
11.4.7. Norway
11.4.7.1. Key country dynamics
11.4.7.2. Competitive scenario
11.4.7.3. Regulatory framework
11.4.7.4. Norway market estimates and forecasts 2021 - 2033 (USD Million)
11.4.8. Sweden
11.4.8.1. Key country dynamics
11.4.8.2. Competitive scenario
11.4.8.3. Regulatory framework
11.4.8.4. Sweden market estimates and forecasts 2021 - 2033 (USD Million)
11.4.9. Denmark
11.4.9.1. Key country dynamics
11.4.9.2. Competitive scenario
11.4.9.3. Regulatory framework
11.4.9.4. Denmark market estimates and forecasts 2021 - 2033 (USD Million)
11.5. Asia Pacific
11.5.1. Asia Pacific market estimates and forecasts 2021 - 2033 (USD Million)
11.5.2. Japan
11.5.2.1. Key country dynamics
11.5.2.2. Competitive scenario
11.5.2.3. Regulatory framework
11.5.2.4. Japan market estimates and forecasts 2021 - 2033 (USD Million)
11.5.3. China
11.5.3.1. Key country dynamics
11.5.3.2. Competitive scenario
11.5.3.3. Regulatory framework
11.5.3.4. China market estimates and forecasts 2021 - 2033 (USD Million)
11.5.4. India
11.5.4.1. Key country dynamics
11.5.4.2. Competitive scenario
11.5.4.3. Regulatory framework
11.5.4.4. India market estimates and forecasts 2021 - 2033 (USD Million)
11.5.5. Australia
11.5.5.1. Key country dynamics
11.5.5.2. Competitive scenario
11.5.5.3. Regulatory framework
11.5.5.4. Australia market estimates and forecasts 2021 - 2033 (USD Million)
11.5.6. South Korea
11.5.6.1. Key country dynamics
11.5.6.2. Competitive scenario
11.5.6.3. Regulatory framework
11.5.6.4. South Korea market estimates and forecasts 2021 - 2033 (USD Million)
11.5.7. Thailand
11.5.7.1. Key country dynamics
11.5.7.2. Competitive scenario
11.5.7.3. Regulatory framework
11.5.7.4. Thailand market estimates and forecasts 2021 - 2033 (USD Million)
11.6. Latin America
11.6.1. Latin America market estimates and forecasts 2021 - 2033 (USD Million)
11.6.2. Brazil
11.6.2.1. Key country dynamics
11.6.2.2. Competitive scenario
11.6.2.3. Regulatory framework
11.6.2.4. Brazil market estimates and forecasts 2021 - 2033 (USD Million)
11.6.3. Argentina
11.6.3.1. Key country dynamics
11.6.3.2. Competitive scenario
11.6.3.3. Regulatory framework
11.6.3.4. Argentina market estimates and forecasts 2021 - 2033 (USD Million)
11.7. MEA
11.7.1. MEA market estimates and forecasts 2021 - 2033 (USD Million)
11.7.2. South Africa
11.7.2.1. Key country dynamics
11.7.2.2. Competitive scenario
11.7.2.3. Regulatory framework
11.7.2.4. South Africa market estimates and forecasts 2021 - 2033 (USD Million)
11.7.3. Saudi Arabia
11.7.3.1. Key country dynamics
11.7.3.2. Competitive scenario
11.7.3.3. Regulatory framework
11.7.3.4. Saudi Arabia market estimates and forecasts 2021 - 2033 (USD Million)
11.7.4. UAE
11.7.4.1. Key country dynamics
11.7.4.2. Competitive scenario
11.7.4.3. Regulatory framework
11.7.4.4. UAE market estimates and forecasts 2021 - 2033 (USD Million)
11.7.5. Kuwait
11.7.5.1. Key country dynamics
11.7.5.2. Competitive scenario
11.7.5.3. Regulatory framework
11.7.5.4. Kuwait market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 12. Competitive Landscape
12.1. Company Categorization
12.2. Strategy Mapping
12.3. Company Market Position Analysis, 2024
12.4. Company Profiles/Listing
12.4.1. Sartorius Inc.
12.4.1.1. Company overview
12.4.1.2. Financial performance
12.4.1.3. Product benchmarking
12.4.1.4. Strategic initiatives
12.4.2. Thermo Fisher Scientific Inc.
12.4.2.1. Company overview
12.4.2.2. Financial performance
12.4.2.3. Product benchmarking
12.4.2.4. Strategic initiatives
12.4.3. Danaher
12.4.3.1. Company overview
12.4.3.2. Financial performance
12.4.3.3. Product benchmarking
12.4.3.4. Strategic initiatives
12.4.4. Merck KgaA
12.4.4.1. Company overview
12.4.4.2. Financial performance
12.4.4.3. Product benchmarking
12.4.4.4. Strategic initiatives
12.4.5. Celltainer Biotech BV
12.4.5.1. Company overview
12.4.5.2. Financial performance
12.4.5.3. Product benchmarking
12.4.5.4. Strategic initiatives
12.4.6. Getinge AB
12.4.6.1. Company overview
12.4.6.2. Financial performance
12.4.6.3. Product benchmarking
12.4.6.4. Strategic initiatives
12.4.7. Eppendorf AG
12.4.7.1. Company overview
12.4.7.2. Financial performance
12.4.7.3. Product benchmarking
12.4.7.4. Strategic initiatives
12.4.8. Cellexus
12.4.8.1. Company overview
12.4.8.2. Financial performance
12.4.8.3. Product benchmarking
12.4.8.4. Strategic initiatives
12.4.9. PBS Biotech Inc.
12.4.9.1. Company overview
12.4.9.2. Financial performance
12.4.9.3. Product benchmarking
12.4.9.4. Strategic initiatives
12.4.10. Lonza
12.4.10.1. Company overview
12.4.10.2. Financial performance
12.4.10.3. Product benchmarking
12.4.10.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us